Aktuellt
SENASTE
Redeye provides its initial comment on BONESUPPORT’s Q3 report. Sales came in c6% above our forecast, and we emphasise that the positive EBIT margin is here to stay. A positive operating cash flow was also achieved, and we dare to say that BONESUPPORT has now begun its profitable growth journey. We anticipate a positive share price reaction of 5-7% during the day.
LÄS MER
